We propose a novel mechanism whereby ficolin-2 contributes to the progression of atherosclerosis independent of complement activation by enhancing inflammation in the cross-talk between the smooth muscle cells and macrophages, key cells in the evolution of atherosclerosis. This evidence concerns the gene FCN2 and atherosclerosis.